U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hydatidiform mole(HYDM)

MedGen UID:
9329
Concept ID:
C0020217
Neoplastic Process
Synonyms: Hydatid mole; Hydatidiform mole, recurrent; Hydatidiform Moles; Molar pregnancy
SNOMED CT: Hydatid mole (417044008); Hydatidiform mole (417044008); Molar pregnancy with hydatid mole (417044008); Molar pregnancy with vesicular mole (417044008)
Modes of inheritance:
Autosomal recessive inheritance
MedGen UID:
141025
Concept ID:
C0441748
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele).
Not genetically inherited
MedGen UID:
988794
Concept ID:
CN307044
Finding
Source: Orphanet
clinical entity without genetic inheritance.
 
HPO: HP:0032192
Monarch Initiative: MONDO:0006248
OMIM®: 231090
OMIM® Phenotypic series: PS231090
Orphanet: ORPHA99927

Definition

Hydatidiform mole (HM) is an aberrant human pregnancy with absence of, or abnormal embryonic development, hydropic degeneration of chorionic villi, and excessive proliferation of the trophoblast. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVHydatidiform mole
Follow this link to review classifications for Hydatidiform mole in Orphanet.

Conditions with this feature

Hydatidiform mole, recurrent, 2
MedGen UID:
481982
Concept ID:
C3280352
Disease or Syndrome
A hydatidiform mole is an abnormal pregnancy characterized by hydropic placental villi, trophoblastic hyperplasia, and poor fetal development. Familial recurrent hydatidiform mole is an autosomal recessive condition in which women experience recurrent pregnancy losses, predominantly complete hydatidiform mole (CHM). However, unlike sporadic CHMs, which are androgenetic with 2 paternal chromosome complements, CHMs associated with familial recurrence are genetically biparental in origin with both a maternal and a paternal contribution to the genome. Other pregnancy losses in this condition include partial hydatidiform mole, stillbirths, ectopic pregnancies, early neonatal deaths, and miscarriages, some of which may be undiagnosed molar pregnancies. Normal pregnancies are extremely rare in families with this condition (summary by Fallahian et al., 2013). For a discussion of genetic heterogeneity of recurrent hydatidiform mole, see HYDM1 (231090).
Hydatidiform mole, recurrent, 1
MedGen UID:
483038
Concept ID:
C3463897
Disease or Syndrome
Hydatidiform moles are not naturally discharged from the body and must be surgically removed, typically by the end of the first trimester. After removal, there is up to a 20 percent risk that any tissue left behind will continue to grow and become a cancerous (malignant) tumor called a persistent mole. If the tumor invades the surrounding tissue of the uterus, it is called an invasive mole. In rare cases, this malignant tumor can transform into a different form of cancer called gestational choriocarcinoma that can spread (metastasize) to other tissues such as the liver, lungs, or brain.\n\nThe first symptom of a hydatidiform mole is often vaginal bleeding in the first trimester of pregnancy. During an ultrasound examination, the abnormal placenta appears as numerous small sacs, often described as resembling a bunch of grapes.\n\nRecurrent hydatidiform mole is a condition that affects women and is characterized by the occurrence of at least two abnormal pregnancies that result in the formation of hydatidiform moles. A hydatidiform mole is a mass that forms early in pregnancy and is made up of cells from an abnormally developed embryo and placenta. Normally, the embryo would develop into a fetus and the placenta would grow to provide nutrients to the growing fetus. When a hydatidiform mole occurs once, it is known as sporadic hydatidiform mole; if it happens again, the condition is known as recurrent hydatidiform mole.
Hydatidiform mole, recurrent, 3
MedGen UID:
1677775
Concept ID:
C5193093
Disease or Syndrome
Hydatidiform mole is a human pregnancy with abnormal or no embryonic development and excessive trophoblastic proliferation. Partial hydatidiform moles have a triploid dispermic genome, with 2 sets of paternal chromosomes and 1 set of maternal chromosomes; complete hydatidiform moles have a diploid androgenetic genome with all chromosomes originating from 1 (monospermic) or 2 (dispermic) sperms, and no maternal chromosomes (summary by Nguyen et al., 2018). For a discussion of genetic heterogeneity of recurrent hydatidiform mole, see HYDM1 (231090).
Hydatidiform mole, recurrent, 4
MedGen UID:
1677210
Concept ID:
C5193094
Disease or Syndrome
Hydatidiform mole is a human pregnancy with abnormal or no embryonic development and excessive trophoblastic proliferation. Partial hydatidiform moles have a triploid dispermic genome, with 2 sets of paternal chromosomes and 1 set of maternal chromosomes; complete hydatidiform moles have a diploid androgenetic genome with all chromosomes originating from 1 (monospermic) or 2 (dispermic) sperms, and no maternal chromosomes (summary by Nguyen et al., 2018). For a discussion of genetic heterogeneity of recurrent hydatidiform mole, see HYDM1 (231090).

Professional guidelines

PubMed

Lukinovic N, Malovrh EP, Takac I, Sobocan M, Knez J
Radiol Oncol 2022 Dec 1;56(4):430-439. Epub 2022 Oct 27 doi: 10.2478/raon-2022-0038. PMID: 36286620Free PMC Article
Soper JT
Obstet Gynecol 2021 Feb 1;137(2):355-370. doi: 10.1097/AOG.0000000000004240. PMID: 33416290Free PMC Article
Eiriksson L, Dean E, Sebastianelli A, Salvador S, Comeau R, Jang JH, Bouchard-Fortier G, Osborne R, Sauthier P
J Obstet Gynaecol Can 2021 Jan;43(1):91-105.e1. doi: 10.1016/j.jogc.2020.03.001. PMID: 33384141

Curated

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Gestational Trophoblastic Neoplasia, 2022

Recent clinical studies

Etiology

Daumová M, Hadravská Š, Putzová M
Cesk Patol 2023 Summer;59(2):50-54. PMID: 37468322
Lukinovic N, Malovrh EP, Takac I, Sobocan M, Knez J
Radiol Oncol 2022 Dec 1;56(4):430-439. Epub 2022 Oct 27 doi: 10.2478/raon-2022-0038. PMID: 36286620Free PMC Article
Massalska D, Bijok J, Kucińska-Chahwan A, Zimowski JG, Ozdarska K, Panek G, Roszkowski T
Clin Genet 2021 Oct;100(4):368-375. Epub 2021 Jun 1 doi: 10.1111/cge.14003. PMID: 34031868
Moein-Vaziri N, Fallahi J, Namavar-Jahromi B, Fardaei M, Momtahan M, Anvar Z
Taiwan J Obstet Gynecol 2018 Feb;57(1):1-6. doi: 10.1016/j.tjog.2017.12.001. PMID: 29458875
Lurain JR
Am J Obstet Gynecol 2010 Dec;203(6):531-9. Epub 2010 Aug 21 doi: 10.1016/j.ajog.2010.06.073. PMID: 20728069

Diagnosis

Daumová M, Hadravská Š, Putzová M
Cesk Patol 2023 Summer;59(2):50-54. PMID: 37468322
Buza N
Surg Pathol Clin 2022 Jun;15(2):197-218. Epub 2022 May 20 doi: 10.1016/j.path.2022.02.002. PMID: 35715158
Fisher RA, Maher GJ
Best Pract Res Clin Obstet Gynaecol 2021 Jul;74:29-41. Epub 2021 Feb 2 doi: 10.1016/j.bpobgyn.2021.01.004. PMID: 33685819
Hui P, Buza N, Murphy KM, Ronnett BM
Annu Rev Pathol 2017 Jan 24;12:449-485. doi: 10.1146/annurev-pathol-052016-100237. PMID: 28135560
Zvandasara P
Cent Afr J Med 1994 Dec;40(12):357-61. PMID: 7882420

Therapy

Laban M, El-Swaify ST, Refaat MA, Ibrahim EA, Abdelrahman RM
Reprod Sci 2021 Oct;28(10):3010-3012. Epub 2021 Aug 2 doi: 10.1007/s43032-021-00703-2. PMID: 34341951
Usui H, Shozu M
N Engl J Med 2021 Mar 11;384(10):936-943. doi: 10.1056/NEJMoa2005756. PMID: 33704938
Eiriksson L, Dean E, Sebastianelli A, Salvador S, Comeau R, Jang JH, Bouchard-Fortier G, Osborne R, Sauthier P
J Obstet Gynaecol Can 2021 Jan;43(1):91-105.e1. doi: 10.1016/j.jogc.2020.03.001. PMID: 33384141
Banerjee D, Barsode SD, Basu P
Rev Recent Clin Trials 2015;10(4):255-62. doi: 10.2174/1574887110666150923111731. PMID: 26411957
Lurain JR
Am J Obstet Gynecol 2010 Dec;203(6):531-9. Epub 2010 Aug 21 doi: 10.1016/j.ajog.2010.06.073. PMID: 20728069

Prognosis

Buza N
Surg Pathol Clin 2022 Jun;15(2):197-218. Epub 2022 May 20 doi: 10.1016/j.path.2022.02.002. PMID: 35715158
Massalska D, Bijok J, Kucińska-Chahwan A, Zimowski JG, Ozdarska K, Panek G, Roszkowski T
Clin Genet 2021 Oct;100(4):368-375. Epub 2021 Jun 1 doi: 10.1111/cge.14003. PMID: 34031868
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L
Int J Gynaecol Obstet 2018 Oct;143 Suppl 2:79-85. doi: 10.1002/ijgo.12615. PMID: 30306586
Lurain JR
Am J Obstet Gynecol 2010 Dec;203(6):531-9. Epub 2010 Aug 21 doi: 10.1016/j.ajog.2010.06.073. PMID: 20728069
Smith MA
Prim Care 1993 Sep;20(3):655-64. PMID: 8378457

Clinical prediction guides

Daumová M, Hadravská Š, Putzová M
Cesk Patol 2023 Summer;59(2):50-54. PMID: 37468322
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L
Int J Gynaecol Obstet 2021 Oct;155 Suppl 1(Suppl 1):86-93. doi: 10.1002/ijgo.13877. PMID: 34669197Free PMC Article
Laban M, El-Swaify ST, Refaat MA, Ibrahim EA, Abdelrahman RM
Reprod Sci 2021 Oct;28(10):3010-3012. Epub 2021 Aug 2 doi: 10.1007/s43032-021-00703-2. PMID: 34341951
Massalska D, Bijok J, Kucińska-Chahwan A, Zimowski JG, Ozdarska K, Panek G, Roszkowski T
Clin Genet 2021 Oct;100(4):368-375. Epub 2021 Jun 1 doi: 10.1111/cge.14003. PMID: 34031868
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L
Int J Gynaecol Obstet 2018 Oct;143 Suppl 2:79-85. doi: 10.1002/ijgo.12615. PMID: 30306586

Recent systematic reviews

Albright BB, Ellett T, Knochenhauer HE, Goins EC, Monuszko KA, Kaplan SJ, Previs RA, Moss HA, Havrilesky LJ, Davidson BA
BJOG 2023 Apr;130(5):443-453. Epub 2023 Jan 25 doi: 10.1111/1471-0528.17374. PMID: 36648416Free PMC Article
Newhouse I, Spacey A, Scragg B, Szczepura K
Radiography (Lond) 2022 Nov;28(4):897-905. Epub 2022 Jul 1 doi: 10.1016/j.radi.2022.06.005. PMID: 35785640
Wang G, Cao J, Xu X, Han X, Cui H
J Gynecol Obstet Hum Reprod 2022 Jan;51(1):102269. Epub 2021 Nov 9 doi: 10.1016/j.jogoh.2021.102269. PMID: 34767996
Zhao Y, Xiong GW, Zhang XW, Hang BO
Anticancer Res 2018 Feb;38(2):1105-1110. doi: 10.21873/anticanres.12329. PMID: 29374747
Deng L, Yan X, Zhang J, Wu T
Cochrane Database Syst Rev 2009 Apr 15;(2):CD005196. doi: 10.1002/14651858.CD005196.pub3. PMID: 19370618

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NCCN, 2022
      NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Gestational Trophoblastic Neoplasia, 2022

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...